Legend Biotech Corp Administrative Expense
Legend Biotech Corp (LEGN) reported Administrative Expense of $135.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdministrativeExpense · last filed 2026-03-10
- Legend Biotech Corp administrative expense for the quarter ending 2025-12-31 was $37.02M, a 8.19% increase year-over-year.
- Legend Biotech Corp administrative expense for the quarter ending 2025-09-30 was $34.72M, a 1.64% decline year-over-year.
- Legend Biotech Corp administrative expense for the quarter ending 2025-06-30 was $32.59M, a 7.80% decline year-over-year.
- Legend Biotech Corp administrative expense for the quarter ending 2025-03-31 was $31.46M, a 1.46% decline year-over-year.
| Period end | Administrative Expense 3 month | Administrative Expense 6 month | Administrative Expense 9 month | Administrative Expense 12 month | Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $37.02M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $71.74M derived: sum of 2 quarters · filed 2026-03-10 | $104.34M derived: sum of 3 quarters · filed 2026-03-10 | $135.80M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $34.72M 6-K · filed 2025-11-12 | $67.31M derived: sum of 2 quarters · filed 2025-11-12 | $98.78M 6-K · filed 2025-11-12 | $133.00M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $32.59M 6-K · filed 2025-08-11 | $64.06M 6-K · filed 2025-08-11 | $98.28M derived: sum of 3 quarters · filed 2026-03-10 | $133.57M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $31.46M 6-K · filed 2025-05-13 | $65.68M derived: sum of 2 quarters · filed 2026-03-10 | $100.98M derived: sum of 3 quarters · filed 2026-03-10 | $136.33M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $34.22M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $69.52M derived: sum of 2 quarters · filed 2026-03-10 | $104.87M derived: sum of 3 quarters · filed 2026-03-10 | $136.80M 20-F · filed 2026-03-10 | $136.78M 20-F · filed 2025-03-11 |
| 2024-09-30 | $35.30M 6-K · filed 2025-11-12 | $70.65M derived: sum of 2 quarters · filed 2025-11-12 | $102.58M 6-K · filed 2025-11-12 | $131.32M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $35.35M 6-K · filed 2025-08-11 | $67.28M 6-K · filed 2025-08-11 | $96.02M derived: sum of 3 quarters · filed 2026-03-10 | $124.12M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | $31.93M 6-K · filed 2025-05-13 | $60.67M derived: sum of 2 quarters · filed 2026-03-10 | $88.77M derived: sum of 3 quarters · filed 2026-03-10 | $116.52M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $28.74M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $56.84M derived: sum of 2 quarters · filed 2026-03-10 | $84.59M derived: sum of 3 quarters · filed 2026-03-10 | $106.80M 20-F · filed 2026-03-10 | $106.77M 20-F · filed 2024-03-19 |
| 2023-09-30 | $28.10M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $55.86M derived: sum of 2 quarters · filed 2024-11-12 | $78.06M 6-K · filed 2024-11-12 | $104.74M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $27.75M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $49.96M 6-K · filed 2024-08-09 | $76.64M derived: sum of 3 quarters · filed 2025-03-11 | $99.88M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $22.20M 6-K · filed 2024-05-13 | $48.89M derived: sum of 2 quarters · filed 2025-03-11 | $72.13M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $26.68M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $49.92M derived: sum of 2 quarters · filed 2025-03-11 | $80.63M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | $23.24M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $53.95M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $30.71M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $46.96M 20-F · filed 2024-03-19 | $46.94M 20-F · filed 2022-03-31 | |||
| 2021-06-30 | $17.99M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $23.13M 20-F · filed 2023-03-30 | $23.15M 20-F · filed 2021-04-02 | |||
| 2020-06-30 | $7.94M 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | $6.75M 20-F/A · filed 2023-02-17 | $6.75M 20-F · filed 2021-04-02 | |||
| 2018-12-31 | $2.77M 20-F · filed 2021-04-02 |